Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study
Van Cutsem, E., Yoshino, T., Lenz, H.J., Lonardi, S., Falcone, A., Limón, M.L., Saunders, M., Sobrero, A., Park, Y.S., Ferreiro, R., Hong, Y.S., Tomasek, J., Taniguchi, H., Ciardiello, F., Stoehr, J., Oum’Hamed, Z., Vlassak, S., Studeny, M., Argiles, G.
Published in Annals of oncology (01.09.2018)
Published in Annals of oncology (01.09.2018)
Get full text
Journal Article
EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity
Hofheinz, R.-D., Lorenzen, S., Trojan, J., Ocvirk, J., Ettrich, T.J., Al-Batran, S.-E., Schulz, H., Homann, N., Feustel, H.-P., Schatz, M., Kripp, M., Schulte, N., Tetyusheva, M., Heeger, S., Vlassak, S., Merx, K.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial
Gaiser, M.R., Lorenzen, S., Merx, K., Trojan, J., Ocvirk, J., Ettrich, T.J., Al-Batran, S.-E., Schulz, H., Homann, N., Feustel, H.-P., Schatz, M., Kripp, M., Schulte, N., Heeger, S., Vlassak, S., Koch, W., Hofheinz, R.-D.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)
Quintela-Fandino, M, Urruticoechea, A, Guerra, J, Gil, M, Gonzalez-Martin, A, Marquez, R, Hernandez-Agudo, E, Rodriguez-Martin, C, Gil-Martin, M, Bratos, R, Escudero, M J, Vlassak, S, Hilberg, F, Colomer, R
Published in British journal of cancer (09.09.2014)
Published in British journal of cancer (09.09.2014)
Get full text
Journal Article
1380P Treatment (Tx) sequencing with tepotinib in previously treated patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION trial
Viteri, S., Felip, E., Griesinger, F., Garassino, M.C., Sakai, H., Le, X., Veillon, R., Smit, E.F., Raskin, J., Thomas, M., Ahn, M-J., Vlassak, S., Bruns, R., Johne, A., Paik, P.K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
33P Real-world experience of MET TKI-induced peripheral edema
Ferrara, R., Vansteenkiste, J.F., Yang, X., Grossi, F., Melosky, B., Ahn, M-J., Calles, A., Chan, O.S.H., Han, B., Bulusu, V.R., Califano, R., Nishino, K., Ghori, V., Ronga, P., Berghoff, K., Vlassak, S., Le, X.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
34P Treatment sequencing in the VISION study of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC
Griesinger, F., Garassino, M.C., Felip, E., Sakai, H., Le, X., Veillon, R., Smit, E.F., Raskin, J., Thomas, M., Ahn, M-J., Vlassak, S., Bruns, R., Johne, A., Paik, P.K.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
EP08.02-162 Tepotinib with an EGFR-Tyrosine Kinase Inhibitor (TKI) in Patients with EGFR-mutant MET-amplified NSCLC: A Case Series
Le, X., Eisert, A., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Tho, L.M., Ahmad, A., Lam, W.-S., Chik, Y.K.J., Lee, W.C.K., Yang, T.-Y., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Wekken, A.v.d.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
364P Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series
Ahmad, A.R., Tho, L.M., Chik, Y.K.J., Lee, W.C.K., Yang, T-Y., Le, X., Eisert, A.K., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Lam, W-S., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Van Der Wekken, A.J., Hsia, T-C.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
gastrointestinal tumours, colorectal Nintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study
Van Cutsem, E., Yoshino, T., Lenz, H.-J., Lonardi, S., Falcone, A., Limon, M.L., Saunders, M.P., Sobrero, A., Maiello, E., Park, Y.S., Monteagudo, R. Ferreiro, Hong, Y.S., Tomasek, J., Taniguchi, H., Ciardiello, F., Hocke, J., Oum'hamed, Z., Vlassak, S., Studeny, M., Tabernero, J.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
Published in The Lancet (British edition) (25.08.2001)
Published in The Lancet (British edition) (25.08.2001)
Get full text
Journal Article
PD-005 Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma
Palmer, D., Meyer, T., Chao, Y., Deptala, A., Fartoux, L., Feng, Y.-H., Graham, J., Lin, D.-Y., Ma, Y.T., Peck-Radosavljevic, M., Ross, P., Ryoo, B.-Y., Yen, C.-J., Hocke, J., Vlassak, S., Wenz, A., Loembe, A.-B., Cheng, A.-L.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
Prediction of pathological response to preoperative chemoradiotherapy with cetuximab in rectal cancer
Machiels, J. H., Debucquoy, A., Gevaert, O., Daemen, A., Sempoux, C., McBride, W., Stroh, C., Vlassak, S., Haustermans, K.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article